| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.12B | 40.47B | 42.55B | 34.23B | 29.67B | 26.04B |
| Gross Profit | 7.34B | 7.44B | 7.68B | 5.73B | 4.36B | 3.21B |
| EBITDA | 5.21B | 5.49B | 6.60B | 5.55B | 3.60B | 2.06B |
| Net Income | 1.70B | 1.79B | 2.22B | 1.02B | 373.65M | -571.96M |
Balance Sheet | ||||||
| Total Assets | 42.33B | 43.72B | 42.68B | 39.28B | 36.84B | 36.90B |
| Cash, Cash Equivalents and Short-Term Investments | 9.50B | 9.68B | 10.33B | 8.55B | 6.82B | 7.10B |
| Total Debt | 4.19B | 4.09B | 4.08B | 6.71B | 8.20B | 9.25B |
| Total Liabilities | 11.80B | 12.66B | 12.53B | 13.96B | 14.12B | 15.74B |
| Stockholders Equity | 24.04B | 24.05B | 22.72B | 18.58B | 16.50B | 15.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 846.36M | 4.87B | 3.51B | 696.34M | 790.61M |
| Operating Cash Flow | 0.00 | 4.42B | 7.42B | 4.98B | 2.37B | 3.06B |
| Investing Cash Flow | 0.00 | -3.13B | -2.82B | -1.11B | -1.56B | -1.44B |
| Financing Cash Flow | 0.00 | -2.10B | -3.66B | -2.67B | -1.39B | -879.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥17.91B | 6.83 | ― | 1.67% | -4.44% | -17.38% | |
75 Outperform | ¥14.60B | 4.37 | ― | 3.90% | -1.72% | 168.62% | |
74 Outperform | ¥12.39B | 7.26 | ― | 2.91% | -3.24% | -26.11% | |
74 Outperform | ¥9.14B | 8.07 | ― | 3.19% | 5.38% | 5.29% | |
66 Neutral | ¥36.74B | 9.29 | ― | 0.55% | 7.65% | ― | |
62 Neutral | ¥20.84B | 4.87 | ― | 4.58% | 34.99% | 468.97% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |